Browsing by Author "Labuschagne, I. L."

Now showing 1 - 6 of 6
  • Thumbnail Image
    Item
    An anti-inflammatory approach to the dietary management of multiple sclerosis : a condensed review
    (Co-published by Medpharm Publications and Taylor & Francis, 2017) Labuschagne, I. L.; Blaauw, Renee
    Multiple sclerosis (MS) is a chronic, inflammatory, neurodegenerative demyelinating disease of the central nervous system (CNS). Inflammation is increased by high-energy Western-style diets, typically high in salt, animal fat, red meat, sugar-sweetened drinks and fried food, and low in fibre, as well as lack of physical exercise. An anti-inflammatory dietary regimen, with or without administration of dietary supplements, supporting the general trend towards an amelioration of inflammatory status, should be considered. Understanding the role of gut microbiota in health and disease can lay the foundation to treat chronic diseases by modifying the composition of gut microbiota through lifestyle choices, including dietary habits and possibly probiotic supplementation. Evidence from experimental, epidemiologic and clinical studies supports the potential association between poor vitamin D status and the risk of developing MS, as well as an adverse disease course. Correcting vitamin D status seems plausible in patients with MS
  • Thumbnail Image
    Item
    The basics of prescribing infant formulas
    (Medpharm Publications, 2012) Owens, C. J. W.; Labuschagne, I. L.; Lombard, Martani J.
    All infant formulas must support the normal growth and development of infants, and this needs to be scientifically demonstrated. Formulas have to contain sufficient amounts of basic nutrients, and so are nutritionally interchangeable, with no evidence indicating that one brand is superior to another.
  • Thumbnail Image
    Item
    Development of a diabetes mellitus nutritional management manual for South African healthcare professionals
    (Taylor & Francis, 2015-02) Rausch, Ursula; Labuschagne, I. L.; Lombard, M. J.
    Background: The objective was to develop a standardised education manual for healthcare professionals in South Africa on the nutritional management of diabetes mellitus. Method: The manual was developed using seven steps: needs assessment and problem definition, a literature search, the first draft of the manual, peer review, the second draft of the manual, expert panel evaluation and the final manual. Results: Following the literature search, the first draft of the manual was developed and sent for peer review and language editing. Recommended changes were made and the second draft was developed and sent to 77 dietitians, of whom the majority were satisfied with the content, which led to the final manual. Conclusion: A diabetes mellitus nutritional management manual for healthcare professionals in South Africa was developed using a systematic approach using peer review and expert panels. The next step will be to evaluate its impact on the knowledge of healthcare professionals.
  • Thumbnail Image
    Item
    Infant formula for gastro-oesophageal reflux disease
    (Medpharm Publications, 2012) Owens, C. J. W.; Labuschagne, I. L.; Lombard, M. J.
    Thickened infant formula is widely used as a first-line treatment for gastro-oesophageal reflux (GOR) in infants. The use thereof remains controversial, and conflicting evidence exists with regards to its efficiency. The safety of anti-reflux formula has been proven, with only a few adverse effects reported, making it safe for infants with mild symptoms of reflux.
  • No Thumbnail Available
    Item
    Optimal nutrition during pregnancy and lactation
    (2012) Labuschagne, I. L.; Ackerberg, T. S.; Lombard, M. J.
  • Thumbnail Image
    Item
    The use of prebiotics and probiotics in infant formula
    (Medpharm Publications, 2012-08) Ackerberg, T. S.; Labuschagne, I. L.; Lombard, M. J.
    Gastrointestinal flora influences health, but the composition of flora can be changed with prebiotics or probiotics. The addition of probiotics to powdered infant formula has not been demonstrated to be harmful to healthy term infants. However, evidence of clinical efficacy regarding their addition is insufficient to recommend the routine use of such formula. The administration of probiotic (single or in combination) supplementation in infant or follow-on formula, and given beyond early infancy, may be associated with some clinical benefits, such as a reduction in the risk of nonspecific gastrointestinal infections, a reduced risk of antibiotic use and a lower frequency of colic and irritability. Confirmatory well-designed clinical research studies are necessary.